logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

Emcure Pharma Share Price

Emcure Pharmaceuticals Ltd.

₹1,604

38.60(2.47%)

Invest in EMCURE with up to 2.86x margin.

Trade with MTF
9th Apr 2026 | 3:28 PM
NSE : EMCURE
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Emcure Pharma Performance

Price Movement

₹1604.00

₹1566.10

₹1615.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1604.00

₹900.00

₹1671.80

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,615.00
Low₹1,566.10
Open at₹1,570.00
Prev Close₹1,565.40
Volumes2.08 L
Avg Price₹1,598.25
Lower Circuit₹1,408.90
Upper Circuit₹1,721.90

Historical Performance

3M High₹1,671.80
3M Low₹1,381.00
1 Yr High₹1,671.80
1 Yr Low₹900.00
3 Yr High₹1,671.80
3 Yr Low₹889.00
5 Yr High₹1,671.80
5 Yr Low₹889.00

Emcure Pharma Fundamentals

Market Cap
High in industry
30,427.20 Cr.
PE Ratio (TTM)
Above industry Median
35
Dividend Yield
Low in industry
0.20
Net Profit TTM
43.2% incr over last year
869.92
Net Profit Growth
43.2% incr over last year
869.92
PEG Ratio
Above industry Median
0.80
ROE
9% decr over last year
15.32
Operating Revenue TTM
8,850.08
Operating Revenue Growth
17.2% incr over last year
Book Value
High in industry
6.10
MFI
MFI is mid-range
67.18
RSI
RSI is mid-range
55.08
EPS (TTM)
36.43
Debt to Equity
0.16
Face Value
10
Operating Profit Margin Qtr.
18.51
Operating Profit Qtr.
492.74
Net Profit Qtr.
230.54
Operating Revenue Qtr.
2,363.48
PB Ratio
6.10

Emcure Pharma Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue1,418.311,260.601,096.571,278.191,028.81
Operating Expense1,117.801,036.01868.571,033.55904.40
Operating Profit300.50224.59228244.64124.42
Depreciation62.1461.7459.8256.9156.65
Interest33.1527.7120.5424.0719.93
Tax55.5140.2742.8846.5017.05
Net Profit258.85117.62122.79139.5650.20

Emcure Pharma Technicals

Emcure Pharmaceuticals Ltd. EMA & SMA

₹1604.00

38.60 (2.47%)

↗ Bullish Moving Average

16

↘ Bearish Moving Average

0

Day EMA5 ₹1562.9
Day EMA10 ₹1556.3
Day EMA12 ₹1552.2
Day EMA20 ₹1536.7
Day EMA26 ₹1528
Day EMA50 ₹1504.6
Day EMA100 ₹1469
Day EMA200 ₹1422.4

Emcure Pharma Support and Resistance

Resistance

First Resistance₹1591.30
Second Resistance₹1617.20
Third Resistance₹1634.40

Support

First Support₹1548.20
Second Support₹1531.00
Third Support₹1505.10

Technical Indicators

Day RSI55.08
Day MFI67.18
Day ADX13.00
Day Commodity Channel Index60.90
William-46.67
Day MACD24.21
Day MACD Signal Line22.10
Day ATR65.08
Day ROC12516.83
Day ROC217.71

Emcure Pharma Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter78.177.977.977.977.977.9
FII2.933.12.93.33.6
DII43.93.42.84.36.1
Public1515.215.616.414.512.4

Emcure Pharma Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day91.97 K1.69 L54.53%
Week1.19 L2.57 L46.16%
1 Month1.28 L3.16 L40.38%
6 Month1.58 L2.99 L52.91%

Emcure Pharma SWOT Analysis

Strengths21
Weakness6
Opportunity6
Threats1

Positive Breakout First Resistance ( LTP > R1)

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Newly Affordable Stocks with Good Financials and Durability (subscription)

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Near 52 Week High

RSI indicating price strength

Top Gainers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Emcure Pharma Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
14 Aug, 20253FINAL14 Aug, 2025Equity Share

Emcure Pharma Stock Comparison

Financials
Anthem Biosciences Ltd.
Sai Life Science Ltd.
Mankind Pharma Ltd.
Gland Pharma Ltd.
Laurus Labs Ltd.
Price (₹)₹720₹975₹2,053₹1,745.10₹1,081.95
% Change4.24%0.15%0.54%0.96%-0.05%
Revenue TTM (₹ Cr)₹1,996.59₹2,169.86₹13,914.08₹6,112.77₹6,721.63
Net Profit TTM (₹ Cr)₹484.66₹332.94₹1,779.35₹847.18₹843.32
PE TTM83.5062.2047.7034.0069.40
1 Year Return26.3643.56-12.4922.787.09
ROCE26.8812.5113.2711.4311.82

Similar Stocks

ALKEM

Alkem Laboratories Ltd.

₹ 5385.00

+2.65%

BIOCON

Biocon Ltd.

₹ 345.95

-1.10%

DIVISLAB

Divi's Laboratories Ltd.

₹ 5955.50

+1.25%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 2750.00

+1.51%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 900.00

-

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2161.80

-0.54%

WOCKPHARMA

Wockhardt Ltd.

₹ 1365.00

+1.13%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1339.20

+0.26%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1715.00

+0.02%

IPCALAB

Ipca Laboratories Ltd.

₹ 1450.00

+0.35%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 1965.10

+1.16%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2357.00

+0.11%

PFIZER

Pfizer Ltd.

₹ 4735.00

-2.08%

ABBOTINDIA

Abbott India Ltd.

₹ 25765.00

-0.33%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4090.00

+1.51%

LUPIN

Lupin Ltd.

₹ 2292.30

-0.08%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1211.00

+1.65%

CIPLA

Cipla Ltd.

₹ 1225.00

+0.75%

FAQ's on EMCURE

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy